Research analysts at Zacks Research boosted their Q1 2025 earnings estimates for Prothena in a research report issued on ...
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
MMA Fighting on MSN6d
Matt Brown argues Alex Pereira didn’t get exposed by Magomed Ankalaev, but ‘I think it humanized him’Matt Brown argues that Alex Pereira losing to Magomed Ankalaev at UFC 313 didn’t expose him as a one-trick pony but it ...
StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note published on Tuesday. The firm issued a hold rating on the stock. Oncternal ...
Hosted on MSN19d
Obinutuzumab Efficacious for Renal Response in Lupus NephritisWEDNESDAY, Feb. 26, 2025 (HealthDay News) -- For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal ... ties to biopharmaceutical companies, including F.
For patients with active lupus nephritis, obinutuzumab, a humanized type II anti-CD20 monoclonal ... to biopharmaceutical companies, including F. Hoffmann-La Roche, which manufactures obinutuzumab ...
REHOVOT, Israel, March 10, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: ...
Will there be a Drive to Survive Season 8? Here's everything we know about its release, returning F1 drivers, and the show's ...
NT219 in combination with EGFR antibody cetuximab (Erbitux) is currently entering a Phase 2 study for head and neck cancer REHOVOT, Israel, March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback